search
Back to results

An Internet-based Information Platform for Vulvodynia Patients (EMBLA)

Primary Purpose

Vulvodynia

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Internet-based platform
Sponsored by
Uppsala University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Vulvodynia

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Vulvodynia patients at their initial evaluation visit to a physician providing written informed consent for participation in the study

Exclusion Criteria:

  • inability to read and understand Swedish
  • severe mental illness
  • currently in treatment for vulvodynia

Sites / Locations

  • Gynecological Department, Akademiska Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Internet-based intervention

Control group

Arm Description

Patients randomized to the internet-based intervention will be given access to the information in the internet-based platform directly after randomization. During the first 6 weeks, information will be offered in a structured way, with a "theme" changing weekly. After this time-point, the patients will have the possibility to navigate through all information. The platform encompasses internet-based training including information on the disorder, psycho-education and information of simple self-implemented intervention strategies cope with vulvodynia and ameliorate dyspareunia. The platform will also include videos where team members will describe their role in treating patients with the disorder, but also short videos from former patients willing to share their individual stories.

Patients randomized to the control group through the platform will immediately be informed about the fact that there is available information and resources on the internet and that they will be called for a visit to the physiotherapist-midwife at due time, according to the present guidelines of care followed in the respective clinic (Uppsala, Falun, Gävle).

Outcomes

Primary Outcome Measures

Unprovoked pain change, post-intervention
Change in self-reported unprovoked pain assessment, assessed by Visual Analogue Scale (VAS), between baseline and post-intervention (6 weeks)
Unprovoked pain change, end of clinical treatment
Change in self-reported unprovoked pain assessment, assessed by Visual Analogue Scale (VAS), between baseline and after completion of clinical treatment or 1 year following inclusion.
Unprovoked pain change, one year post-treatment
Change in self-reported unprovoked pain assessment, assessed by Visual Analogue Scale (VAS), between baseline and 1 year after completion of clinical treatment.
Provoked pain change, post-intervention
Change in self-reported provoked pain assessment, assessed by Visual Analogue Scale (VAS), between baseline and post-intervention (6 weeks)
Provoked pain change, end of clinical treatment
Change in self-reported provoked pain assessment, assessed by Visual Analogue Scale (VAS), between baseline and after completion of clinical treatment or 1 year following inclusion.
Provoked pain change, one year post-treatment
Change in self-reported unprovoked pain assessment, assessed by Visual Analogue Scale (VAS), between baseline and 1 year after completion of clinical treatment.

Secondary Outcome Measures

Satisfaction with Life change
Change in satisfaction with Life, assessed with Satisfaction with Life Scale, between baseline and post-intervention (6 weeks)
Sexuality
Change in sexuality measures, assessed by Female Sexual Function Index (FSFI)
Number of visits for clinical treatment
Number of visits for clinical treatment
Cost-effectiveness, assessed with the EQ-5D scale
Cost-effectiveness, assessed with the EQ-5D scale, from baseline to one year after completion of clinica treatment
Sexual function parameters
Change in sexual function parameters, assessed by the Female Sexual Dysfunction Scale (SFDS), between baseline and completion of clinical treatment
Number of days off work
Satisfaction with Life change, one year post-treatment
Change in satisfaction with Life, assessed with Satisfaction with Life Scale, between baseline and one year after completion of clinical treatment

Full Information

First Posted
March 9, 2016
Last Updated
April 27, 2021
Sponsor
Uppsala University
search

1. Study Identification

Unique Protocol Identification Number
NCT02809612
Brief Title
An Internet-based Information Platform for Vulvodynia Patients
Acronym
EMBLA
Official Title
The EMBLA Project - An Internet-based Intervention as a Supplement to Clinical Management for Vulvodynia Patients
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
March 2016 (Actual)
Primary Completion Date
September 30, 2020 (Actual)
Study Completion Date
September 30, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Uppsala University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Vulvodynia is a very common but vastly under-diagnosed and under-treated gynaecological condition that leads to extreme suffering for both the women involved but also their partners. It has also been shown to be associated with poor quality of life, leading to depression and anxiety states. When left untreated, the condition takes a very long time to resolve, with a substantial associated disability and suffering. Both psycho-education and internet-based interventions have been shown to be highly successful while they can be quite affordable. This makes them highly cost-effective. The present study aims at evaluating the effectiveness of such an intervention among a vulvodynia patient population from the clinics of Uppsala, Falun, Orebro and Gävle. The patients will be recruited by treating physicians and given access to the internet-based platform, where they will fill out questionnaires during four different time-points, after randomization to the control or the intervention group. The intervention group will also have access to multiple activities and information material uploaded in the internet-based platform. Differences in pain, quality of life and mental health parameter outcomes will be assessed at the end of the study. Should this intervention prove effective, it will be implemented in clinical praxis in the four regions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Vulvodynia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
52 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Internet-based intervention
Arm Type
Experimental
Arm Description
Patients randomized to the internet-based intervention will be given access to the information in the internet-based platform directly after randomization. During the first 6 weeks, information will be offered in a structured way, with a "theme" changing weekly. After this time-point, the patients will have the possibility to navigate through all information. The platform encompasses internet-based training including information on the disorder, psycho-education and information of simple self-implemented intervention strategies cope with vulvodynia and ameliorate dyspareunia. The platform will also include videos where team members will describe their role in treating patients with the disorder, but also short videos from former patients willing to share their individual stories.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Patients randomized to the control group through the platform will immediately be informed about the fact that there is available information and resources on the internet and that they will be called for a visit to the physiotherapist-midwife at due time, according to the present guidelines of care followed in the respective clinic (Uppsala, Falun, Gävle).
Intervention Type
Behavioral
Intervention Name(s)
Internet-based platform
Intervention Description
Internet-based platform with information and training modules based on acceptance and commitment therapy for vulvodynia patients
Primary Outcome Measure Information:
Title
Unprovoked pain change, post-intervention
Description
Change in self-reported unprovoked pain assessment, assessed by Visual Analogue Scale (VAS), between baseline and post-intervention (6 weeks)
Time Frame
Baseline to post-intervention (6 weeks)
Title
Unprovoked pain change, end of clinical treatment
Description
Change in self-reported unprovoked pain assessment, assessed by Visual Analogue Scale (VAS), between baseline and after completion of clinical treatment or 1 year following inclusion.
Time Frame
Baseline to end of clinical treatment (typically 10-12 months) or 1 year following inclusion
Title
Unprovoked pain change, one year post-treatment
Description
Change in self-reported unprovoked pain assessment, assessed by Visual Analogue Scale (VAS), between baseline and 1 year after completion of clinical treatment.
Time Frame
1 year after end of clinical treatment
Title
Provoked pain change, post-intervention
Description
Change in self-reported provoked pain assessment, assessed by Visual Analogue Scale (VAS), between baseline and post-intervention (6 weeks)
Time Frame
post-intervention (6 weeks)
Title
Provoked pain change, end of clinical treatment
Description
Change in self-reported provoked pain assessment, assessed by Visual Analogue Scale (VAS), between baseline and after completion of clinical treatment or 1 year following inclusion.
Time Frame
after clinical treatment (typically 10-12 months) or 1 year following inclusion
Title
Provoked pain change, one year post-treatment
Description
Change in self-reported unprovoked pain assessment, assessed by Visual Analogue Scale (VAS), between baseline and 1 year after completion of clinical treatment.
Time Frame
1 year after ending of clinical treatment
Secondary Outcome Measure Information:
Title
Satisfaction with Life change
Description
Change in satisfaction with Life, assessed with Satisfaction with Life Scale, between baseline and post-intervention (6 weeks)
Time Frame
Baseline to post-intervention (6 weeks)
Title
Sexuality
Description
Change in sexuality measures, assessed by Female Sexual Function Index (FSFI)
Time Frame
Baseline to post-intervention (6 weeks)
Title
Number of visits for clinical treatment
Description
Number of visits for clinical treatment
Time Frame
One year after the end of clinical treatment
Title
Cost-effectiveness, assessed with the EQ-5D scale
Description
Cost-effectiveness, assessed with the EQ-5D scale, from baseline to one year after completion of clinica treatment
Time Frame
Baseline to one year after completion of clinical treatment
Title
Sexual function parameters
Description
Change in sexual function parameters, assessed by the Female Sexual Dysfunction Scale (SFDS), between baseline and completion of clinical treatment
Time Frame
Baseline to end of clinical treatment
Title
Number of days off work
Time Frame
Baseline to end of clinical treatment
Title
Satisfaction with Life change, one year post-treatment
Description
Change in satisfaction with Life, assessed with Satisfaction with Life Scale, between baseline and one year after completion of clinical treatment
Time Frame
Baseline to one year post-treatment

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Vulvodynia patients at their initial evaluation visit to a physician providing written informed consent for participation in the study Exclusion Criteria: inability to read and understand Swedish severe mental illness currently in treatment for vulvodynia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alkistis Skalkidou, MD, PhD
Organizational Affiliation
Dept of Women's and Children's Health, Uppsala University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gynecological Department, Akademiska Hospital
City
Uppsala
ZIP/Postal Code
75185
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
17194952
Citation
Haefner HK. Report of the International Society for the Study of Vulvovaginal Disease terminology and classification of vulvodynia. J Low Genit Tract Dis. 2007 Jan;11(1):48-9. doi: 10.1097/01.lgt.0000225898.37090.04. No abstract available.
Results Reference
background
PubMed Identifier
17306651
Citation
Arnold LD, Bachmann GA, Rosen R, Rhoads GG. Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control study. Am J Obstet Gynecol. 2007 Feb;196(2):128.e1-6. doi: 10.1016/j.ajog.2006.07.047.
Results Reference
background
PubMed Identifier
12744420
Citation
Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc (1972). 2003 Spring;58(2):82-8.
Results Reference
background
PubMed Identifier
15870521
Citation
Haefner HK, Collins ME, Davis GD, Edwards L, Foster DC, Hartmann ED, Kaufman RH, Lynch PJ, Margesson LJ, Moyal-Barracco M, Piper CK, Reed BD, Stewart EG, Wilkinson EJ. The vulvodynia guideline. J Low Genit Tract Dis. 2005 Jan;9(1):40-51. doi: 10.1097/00128360-200501000-00009.
Results Reference
background
PubMed Identifier
19403215
Citation
Amstadter AB, Broman-Fulks J, Zinzow H, Ruggiero KJ, Cercone J. Internet-based interventions for traumatic stress-related mental health problems: a review and suggestion for future research. Clin Psychol Rev. 2009 Jul;29(5):410-20. doi: 10.1016/j.cpr.2009.04.001. Epub 2009 Apr 7.
Results Reference
background
PubMed Identifier
23739312
Citation
Tursi MF, Baes Cv, Camacho FR, Tofoli SM, Juruena MF. Effectiveness of psychoeducation for depression: a systematic review. Aust N Z J Psychiatry. 2013 Nov;47(11):1019-31. doi: 10.1177/0004867413491154. Epub 2013 Jun 5.
Results Reference
background
PubMed Identifier
18937129
Citation
Backman H, Widenbrant M, Bohm-Starke N, Dahlof LG. Combined physical and psychosexual therapy for provoked vestibulodynia-an evaluation of a multidisciplinary treatment model. J Sex Res. 2008 Oct-Dec;45(4):378-85. doi: 10.1080/00224490802398365.
Results Reference
background
PubMed Identifier
21080898
Citation
Bohm-Starke N. Medical and physical predictors of localized provoked vulvodynia. Acta Obstet Gynecol Scand. 2010 Dec;89(12):1504-10. doi: 10.3109/00016349.2010.528368.
Results Reference
background
PubMed Identifier
22376009
Citation
Heddini U, Bohm-Starke N, Nilsson KW, Johannesson U. Provoked vestibulodynia--medical factors and comorbidity associated with treatment outcome. J Sex Med. 2012 May;9(5):1400-6. doi: 10.1111/j.1743-6109.2012.02665.x. Epub 2012 Feb 29.
Results Reference
background
PubMed Identifier
19879555
Citation
Desrochers G, Bergeron S, Khalife S, Dupuis MJ, Jodoin M. Provoked vestibulodynia: psychological predictors of topical and cognitive-behavioral treatment outcome. Behav Res Ther. 2010 Feb;48(2):106-15. doi: 10.1016/j.brat.2009.09.014. Epub 2009 Oct 7.
Results Reference
background
Citation
Wijma B, Wijma K. A Cognitive Behavioral Treatment Model of Vaginismus. Scand J Behav Ther 1997;26:147-156.
Results Reference
background
Citation
Palm A, Danielsson I. SFOGs ARG-rapport för tonårsgynekologi. Sexuell och reproduktiv hälsa hos ungdomar 2013:73-76.
Results Reference
background
Citation
Chapple CR, Zimmern PE, Brubaker L, Smith ARB, Bo K. Multidisciplinary Management of Female Pelvic Floor Disorders. Philadelphia: Churchill Livingstone Elsevier; 2006.
Results Reference
background
PubMed Identifier
33996511
Citation
Hess Engstrom AH, Kullinger M, Jawad I, Hesselman S, Buhrman M, Hogberg U, Skalkidou A. Internet-based treatment for vulvodynia (EMBLA) - Study protocol for a randomised controlled study. Internet Interv. 2021 Apr 20;25:100396. doi: 10.1016/j.invent.2021.100396. eCollection 2021 Sep.
Results Reference
derived
Available IPD and Supporting Information:
Available IPD/Information Type
Study Protocol
Available IPD/Information URL
http://www.kbh.uu.se

Learn more about this trial

An Internet-based Information Platform for Vulvodynia Patients

We'll reach out to this number within 24 hrs